Pure Global
NCT06413823

Prevention and Treatment of Cardiovascular Disease

Prevention and Treatment of Cardiovascular Disease: Protocol for the Assessment of Psychological, Neuropsychological Implications and Associated Disorders in Cardiology Patients
IRCCS Centro Neurolesi Bonino-Pulejo·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cardiovascular Disease
Study type
Observational
Sponsor & location
Primary sponsor
IRCCS Centro Neurolesi Bonino-Pulejo
Location
Messina, Italy
Timeline & enrollment
Phase
N/A
Start date
May 09, 2024
End date
May 13, 2026
Enrollment
218 participants
Primary outcome

effectiveness of psychoeducation

Summary

In view of the close interrelationship between the various organs and systems of the body,
 which cannot be examined in a parceled fashion but rather as an integrated system, this study
 aims to consider the potential risks associated with cardiovascular disease.
 
 By identifying additional, often underestimated, altered functions that may affect the
 patient's quality of life and interfere with the performance of daily activities, this
 research study aims to evaluate the patient's functioning in an integrated manner to achieve
 a holistic view of the health and well-being of the patient and caregiver.

ICD-10 classifications
Cardiovascular disease, unspecifiedHypertensive heart diseaseHeart disease, unspecifiedAtherosclerotic cardiovascular disease, so describedAtherosclerotic heart disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06413823
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06413823 through Pure Global AI's free database. This phase not specified trial is sponsored by IRCCS Centro Neurolesi Bonino-Pulejo and is currently Recruiting. The study focuses on Cardiovascular Disease. Target enrollment is 218 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.